These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 17227498

  • 1. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
    Wespes E, Moncada I, Schmitt H, Jungwirth A, Chan M, Varanese L.
    BJU Int; 2007 Jan; 99(1):121-6. PubMed ID: 17227498
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.
    Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van Ahlen H, Wespes E, Cordell WH, Chan M, Lembo D, Varanese L.
    Eur Urol; 2005 Jun; 47(6):846-54; discussion 854. PubMed ID: 15925082
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM, Hague JA, Ahuja S.
    J Androl; 2005 Jun; 26(3):310-8. PubMed ID: 15866997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.
    Am J Cardiol; 2006 Jun 15; 97(12):1778-84. PubMed ID: 16765134
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.
    Arch Neurol; 2007 Nov 15; 64(11):1584-92. PubMed ID: 17846260
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sexual intercourse attempt patterns with two dosing regimens of tadalafil in men with erectile dysfunction: results from the SURE study in 14 European countries.
    Moncada I, Damber JE, Mirone V, Wespes E, Casariego J, Chan M, Varanese L.
    J Sex Med; 2005 Sep 15; 2(5):668-74. PubMed ID: 16422825
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, Lim E, Shen W, Venugopalan M, Chan M.
    Int J Urol; 2006 Jun 15; 13(6):721-7. PubMed ID: 16834650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS.
    Asian J Androl; 2007 Nov 15; 9(6):760-70. PubMed ID: 17968461
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L, Slagter C, Slob AK, Hop WC.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):439-44. PubMed ID: 16965992
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
    von Keitz A, Rajfer J, Segal S, Murphy A, Denne J, Costigan T, Lockhart D, Beasley CM, Emmick JT.
    Eur Urol; 2004 Apr 01; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
    Montorsi F, Verheyden B, Meuleman E, Jünemann KP, Moncada I, Valiquette L, Casabé A, Pacheco C, Denne J, Knight J, Segal S, Watkins VS.
    Eur Urol; 2004 Mar 01; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.